David McDermott, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exelixis
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    X4 Pharma
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Peloton Therapeutics
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Jounce Therapeutics
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Eli Lilly and Company
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Prometheus Laboratories
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech BioOncology
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Array BioPharm
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exelixis
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    BMS
    Date added:
    Date updated:
    12/22/2021

Pages

Return to Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2020)